Skip to main content
. 2018 Jun 4;23(5):1055–1068. doi: 10.1007/s12192-018-0915-0

Fig. 1.

Fig. 1

Screening for hypoxia modulating drugs. a Schematic diagram showing the screening assay protocol for hypoxia modulating drugs. b HIF-1α-driven Luciferase assay for U2OS cells stably transfected with HRE-luciferase plasmid. c HIF-reporter assay in cells treated with natural drugs (5.0 mM). Out of the 57 drugs tested, 5 compounds (shown by dark bars) showed strong pro-hypoxia activity and 4 compounds (shown by white bars) showed anti-hypoxia activity